ARCHIVES

Outside Experts Might Lengthen NDA Approval, Peck Asserts

This article is from The Cancer Letter archive.

Vol. 16 No. 34 | September 7, 1990

Download PDF Visit The Full Archive

Related Articles

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

May 20, 2005

Novel Agents Promise Relief From Hematologic Side Effects

July 27, 2001

Niederhuber says his job is easy, but times are hard: NCI may need to cut up to $150 million.

December 9, 2005

WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use

November 2, 2002

Separation Will Make Interaction Easier; AACR President Says

June 26, 1992

In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div.

February 28, 1992